• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泪腺原发性导管腺癌:两例报告并文献复习

Primary ductal adenocarcinoma of lacrimal gland: Two case reports and review of the literature.

作者信息

Yang Hsin-Yu, Wu Cheng-Hsien, Tsai Chieh-Chih, Yu Wei-Kuang, Kao Shu-Ching, Liu Catherine Jui-Ling

机构信息

Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan.

School of Medicine, National Yang-Ming University, Taipei, Taiwan.

出版信息

Taiwan J Ophthalmol. 2018 Jan-Mar;8(1):42-48. doi: 10.4103/tjo.tjo_3_18.

DOI:10.4103/tjo.tjo_3_18
PMID:29675349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5890584/
Abstract

A 64-year-old male presented with progressive proptosis of the left eye for 3 months. Orbital computed tomography (CT) demonstrated a 3.9 cm infiltrative mass over the superotemporal quadrant of the left orbit. Pathology of biopsy revealed a ductal adenocarcinoma of lacrimal gland with positive immunohistochemical staining for androgen receptor (AR), cytokeratin-7 (CK7), and gross cystic disease fluid protein 15 (GCDFP-15). The patient received orbital exenteration and adjuvant chemoradiotherapy. No recurrence or metastasis was noted 27 months after treatment. Another case was a 64-year-old male who came for proptosis of the right eye and diplopia for 3 weeks. Orbital CT revealed a 5 cm infiltrated right superotemporal orbital mass with destruction of the lateral and inferior orbital walls. Biopsy showed primary ductal adenocarcinoma of lacrimal gland with positive immunohistochemical staining for CK7, AR, and epidermal growth factor receptor. The patient underwent exenteration and concomitant chemoradiotherapy. However, lung and neck metastasis was noted 21 months after surgery. Collectively, 26 cases in the literature were reviewed. The mean age was 57 years old and male was prevalent (73%). Most immunohistological staining showed positive for AR (46%), CK7 (46%), Ki-67 (38%), and GCDFP-15 (35%). More than half of the patients developed metastasis and one-third of the patients died of disease. Early diagnosis, treatment, and long-term follow-up are required for this aggressive tumor.

摘要

一名64岁男性,左眼进行性眼球突出3个月。眼眶计算机断层扫描(CT)显示左眼眶颞上象限有一个3.9厘米的浸润性肿块。活检病理显示为泪腺导管腺癌,雄激素受体(AR)、细胞角蛋白-7(CK7)和 gross cystic disease fluid protein 15(GCDFP-15)免疫组化染色呈阳性。患者接受了眼眶内容剜除术及辅助放化疗。治疗27个月后未发现复发或转移。另一例是一名64岁男性,因右眼眼球突出和复视3周前来就诊。眼眶CT显示右颞上眶有一个5厘米的浸润性肿块,眼眶外侧壁和下壁破坏。活检显示为泪腺原发性导管腺癌,CK7、AR和表皮生长因子受体免疫组化染色呈阳性。患者接受了内容剜除术及同步放化疗。然而,术后21个月发现有肺和颈部转移。综合来看,对文献中的26例病例进行了回顾。平均年龄为57岁,男性居多(73%)。大多数免疫组织化学染色显示AR(46%)、CK7(46%)、Ki-67(38%)和GCDFP-15(35%)呈阳性。超过一半的患者发生转移,三分之一的患者死于该疾病。对于这种侵袭性肿瘤,需要早期诊断、治疗和长期随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9956/5890584/a5e15ea827ca/TJO-8-42-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9956/5890584/b5651c087b27/TJO-8-42-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9956/5890584/a5e15ea827ca/TJO-8-42-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9956/5890584/b5651c087b27/TJO-8-42-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9956/5890584/a5e15ea827ca/TJO-8-42-g002.jpg

相似文献

1
Primary ductal adenocarcinoma of lacrimal gland: Two case reports and review of the literature.泪腺原发性导管腺癌:两例报告并文献复习
Taiwan J Ophthalmol. 2018 Jan-Mar;8(1):42-48. doi: 10.4103/tjo.tjo_3_18.
2
GCDFP-15, AR, and Her-2 as biomarkers for primary ductal adenocarcinoma of the lacrimal gland: a Chinese case and literature review.GCDFP-15、雄激素受体及人表皮生长因子受体2作为泪腺原发性导管腺癌生物标志物的研究:1例中国病例及文献综述
Onco Targets Ther. 2015 May 11;8:1017-24. doi: 10.2147/OTT.S82168. eCollection 2015.
3
Primary apocrine adenocarcinoma of the lacrimal sac: an extremely rare variant of lacrimal sac neoplasm.原发性大汗腺癌:一种极其罕见的泪囊肿瘤变异型。
Orbit. 2022 Apr;41(2):241-244. doi: 10.1080/01676830.2020.1825752. Epub 2020 Sep 23.
4
Primary ductal adenocarcinoma of the lacrimal gland: case report.泪腺原发性导管腺癌:病例报告
Arq Bras Oftalmol. 2012 Jan-Feb;75(1):64-6. doi: 10.1590/s0004-27492012000100014.
5
Breast carcinoma metastasis to the lacrimal gland: Two case reports.乳腺癌转移至泪腺:两例报告。
Oncol Lett. 2015 Aug;10(2):1031-1035. doi: 10.3892/ol.2015.3282. Epub 2015 May 27.
6
A case of primary ductal adenocarcinoma of the lacrimal gland: histopathological and immunohistochemical study.一例泪腺原发性导管腺癌:组织病理学和免疫组织化学研究
Pathol Res Pract. 2005;201(1):49-53. doi: 10.1016/j.prp.2004.11.003.
7
Primary ductal adenocarcinoma of the lacrimal gland with sarcomatoid differentiation: case report and genomic analysis.原发性泪腺导管腺癌伴肉瘤样分化:病例报告及基因组分析。
Orbit. 2024 Oct;43(5):640-644. doi: 10.1080/01676830.2023.2246156. Epub 2023 Aug 23.
8
Adenocarcinoma of the lacrimal gland: a case report.泪腺腺癌:一例报告
J Med Case Rep. 2017 Sep 11;11(1):257. doi: 10.1186/s13256-017-1412-2.
9
Epithelial Lacrimal Gland Tumours in Nigeria: Clinicopathological Features and Treatment.尼日利亚的上皮性泪腺肿瘤:临床病理特征与治疗
J West Afr Coll Surg. 2020 Apr-Jun;10(2):5-11. doi: 10.4103/jwas.jwas_33_21. Epub 2022 Mar 26.
10
Primary ductal adenocarcinoma of the lacrimal gland with changing genetic analysis mutations.泪腺原发性导管腺癌伴基因分析突变改变
Orbit. 2018 Dec;37(6):463-467. doi: 10.1080/01676830.2018.1437191. Epub 2018 Feb 9.

引用本文的文献

1
Hybrid neoplasm of the lacrimal gland, adenocarcinoma NOS with primary squamous cell carcinoma; A rare case report.泪腺混合性肿瘤,非特殊类型腺癌伴原发性鳞状细胞癌;1例罕见病例报告。
J Oral Biol Craniofac Res. 2025 Nov-Dec;15(6):1200-1203. doi: 10.1016/j.jobcr.2025.07.025. Epub 2025 Aug 7.
2
The poor prognosis of lacrimal gland adenocarcinoma: a clinical study and literature review.泪腺癌预后不良:临床研究和文献回顾。
J Cancer Res Clin Oncol. 2024 Jan 23;150(1):26. doi: 10.1007/s00432-023-05510-7.
3
Metastatic lacrimal/salivary gland duct adenocarcinoma.

本文引用的文献

1
Lacrimal gland ductal carcinomas: Clinical, Morphological and Genetic characterization and implications for targeted treatment.泪腺导管癌:临床、形态学及遗传学特征及其对靶向治疗的意义
Acta Ophthalmol. 2017 May;95(3):299-306. doi: 10.1111/aos.13310. Epub 2016 Nov 3.
2
A benign presentation of primary ductal adenocarcinoma of lacrimal gland: A rare malignancy.泪腺原发性导管腺癌的良性表现:一种罕见的恶性肿瘤。
Indian J Ophthalmol. 2015 Nov;63(11):856-8. doi: 10.4103/0301-4738.171969.
3
GCDFP-15, AR, and Her-2 as biomarkers for primary ductal adenocarcinoma of the lacrimal gland: a Chinese case and literature review.
转移性泪腺/涎腺导管腺癌。
BMJ Case Rep. 2023 Jun 30;16(6):e253928. doi: 10.1136/bcr-2022-253928.
4
Rare Diseases of the Orbit.眼眶部罕见病
Laryngorhinootologie. 2021 Apr;100(S 01):S1-S79. doi: 10.1055/a-1384-4641. Epub 2021 Apr 30.
5
De novo adenocarcinoma of the lacrimal gland: Case report.泪腺原发性腺癌:病例报告
Ann Med Surg (Lond). 2021 Mar 25;64:102234. doi: 10.1016/j.amsu.2021.102234. eCollection 2021 Apr.
6
Primary ductal adenocarcinoma of the lacrimal gland: A review and report of five cases.原发性泪腺导管腺癌:复习与五例报告。
Surv Ophthalmol. 2020 May-Jun;65(3):371-380. doi: 10.1016/j.survophthal.2019.11.002. Epub 2019 Dec 16.
GCDFP-15、雄激素受体及人表皮生长因子受体2作为泪腺原发性导管腺癌生物标志物的研究:1例中国病例及文献综述
Onco Targets Ther. 2015 May 11;8:1017-24. doi: 10.2147/OTT.S82168. eCollection 2015.
4
Metastatic, her-2 amplified lacrimal gland carcinoma with response to lapatinib treatment.转移性、her-2扩增泪腺癌对拉帕替尼治疗有反应。
Case Rep Oncol Med. 2015;2015:262357. doi: 10.1155/2015/262357. Epub 2015 Feb 2.
5
Single bone metastasis from adenocarcinoma of the lacrimal gland: a case report.泪腺腺癌的单发性骨转移:一例报告
Future Oncol. 2014 Aug;10(10):1735-9. doi: 10.2217/fon.14.36.
6
Primary ductal adenocarcinoma of the lacrimal gland, associated with abundant intracytoplasmic lumens containing some eosinophilic hyaline globules: cytological, histological and ultrastructural findings.泪腺原发性导管腺癌,伴有大量含嗜酸性透明小球的胞质内管腔:细胞学、组织学及超微结构发现
Ultrastruct Pathol. 2014 Oct;38(5):363-6. doi: 10.3109/01913123.2014.921656. Epub 2014 Jun 16.
7
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.人表皮生长因子受体 2 检测在乳腺癌中的应用:美国临床肿瘤学会/美国病理学家学会临床实践指南更新。
J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7.
8
Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: five new cases and review of literature.泪腺原发性导管腺癌的临床病理和免疫组化特征:五例新病例并文献复习。
Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):2071-6. doi: 10.1007/s00417-013-2350-3. Epub 2013 Apr 24.
9
Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients.他莫昔芬对雌激素受体阴性孕激素受体阳性低级别乳腺癌患者的生存获益。
J Breast Cancer. 2012 Sep;15(3):288-95. doi: 10.4048/jbc.2012.15.3.288. Epub 2012 Sep 28.
10
Effectiveness of prophylactic retropharyngeal lymph node irradiation in patients with locally advanced head and neck cancer.局部晚期头颈部癌症患者预防性咽后淋巴结照射的疗效。
BMC Cancer. 2012 Jun 18;12:253. doi: 10.1186/1471-2407-12-253.